China Premiere of 'Avatar: Fire and Ash' Highlight of 7th HIIFF
HAIKOU, China, Dec. 10, 2025 /PRNewswire/ -- A report from Hainan International Media Center: On the evening of Dec. 9th, the 7th Hainan Island International Film Festival (HIIFF) concluded. This thrilling event was held just prior to the imminent...
NaaS Technology Inc. Regains Compliance with Nasdaq Minimum Market Value of Listed Securities Requirement
BEIJING, Dec. 10, 2025 /PRNewswire/ -- NaaS Technology Inc. (Nasdaq: NAAS) ("NaaS" or the "Company"), the first U.S.-listed EV charging service company in China, today announced that on December 9, 2025, it received written notice from the Listing...
Culture and tourism sectors thrive in Xiamen
BEIJING, Dec. 10, 2025 /PRNewswire/ -- A report from China Daily: China Daily publishes an eight-page spread on Wednesday to showcase Xiamen’s high-quality development during 2021-25. Driven by its commitment to high-level opening-up, Xiamen, Fujian...
Dizal Showcases its Strong Hematology Pipeline with New Data from Golidocitinib and Birelentinib at ASH 2025
SHANGHAI, Dec. 9, 2025 /PRNewswire/ -- Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for cancer and immunological diseases, announced new data from its hematology portfolio at the 67th American Society of...
Keio Plaza Hotel Tokyo Wins Grand Prize at Eco Mark Award 2025
- Keio Plaza Hotel Recognized for Its Company-wide Sustainability Promotion, Food Waste Reduction and Installation of Clothing Collection Boxes - TOKYO, Dec. 9, 2025 /PRNewswire/ -- Keio Plaza Hotel Co., Ltd. received the highest award, the Grand...
Innovent Announces PECONDLE® (Picankibart Injection) Phase 3 Study (CLEAR-2) Meets Endpoints, Delivering Superior Long-Term Management Solution for Moderate-to-Severe Psoriasis
SAN FRANCISCO and SUZHOU, China, Dec. 9, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...
Lunit Submits 510(k) Application for Image-Based Breast Cancer Risk Prediction Model
Submission marks a key regulatory milestone toward bringing SEER-calibrated, imaging-based risk assessment to U.S. screening programs SEOUL, South Korea, Dec. 8, 2025 /PRNewswire/ -- Lunit (KRX:328130), a leading provider of AI for cancer...
Global Shift Toward Trust: 2025 Employer Branding Creativity Awards Highlight New Talent Trends
XISHUANGBANNA, China, Dec. 8, 2025 /PRNewswire/ -- As global competition for talent intensifies, organisations are increasingly elevating employer branding from a recruitment-focused activity to a core strategic capability. Authentic storytelling,...
Yidan Prize Foundation connects global insights and local expertise at annual flagship Summit
500 changemakers from over 50 countries stand in solidarity with Hong Kong and co-create paths forward through education HONG KONG, Dec. 6, 2025 /PRNewswire/ -- The Yidan Prize Foundation, the Hong Kong-based global philanthropic foundation,...
Hope Medicine Inc.'s HMI-115 Received U.S. FDA Fast Track Designation, Accelerating Global Development
HMI-115 received FDA Fast Track Designation based on results from a Phase II clinical trial for endometriosis Mean dysmenorrhea pain score reduced by 42% Mean non-menstrual chronic pelvic pain score reduced by 52% Most patients maintained normal...